Slavisa Gasic
Hematology & Oncology · San Antonio, TXNPI 1558403337
Payments from drug & device makers
Across 132 payments — averaging $253.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$30K
- AstraZeneca$576
- Pfizer$287
- Novartis$193
- Astellas Pharma US Inc$189
- Incyte Corporation$172
- plus $2K from 30 others
What the payments were for
- Food & beverage$2,94193%
- Education$2317%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 11 | $30,386 |
| AstraZeneca | 15 | $576 |
| Pfizer | 14 | $287 |
| Novartis | 12 | $193 |
| Astellas Pharma US Inc | 7 | $189 |
| Incyte Corporation | 4 | $172 |
| Boehringer Ingelheim | 2 | $143 |
| E.r. Squibb & Sons, L.L.C. | 12 | $135 |
| AbbVie | 2 | $121 |
| AVEO Pharmaceuticals, Inc. | 2 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $110 |
| Tesaro, Inc. | 1 | $88 |
| Lilly USA, LLC | 5 | $74 |
| Regeneron Healthcare Solutions, Inc. | 2 | $71 |
| Sanofi | 3 | $67 |
| Genentech USA, Inc. | 3 | $66 |
| Eisai Inc. | 3 | $61 |
| Bayer | 4 | $60 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| Exelixis Inc. | 2 | $47 |
| Amgen | 3 | $46 |
| Johnson & Johnson | 3 | $43 |
| Tersera Therapeutics LLC | 2 | $41 |
| Coherus Oncology, Inc. | 1 | $31 |
| AMAG Pharmaceuticals, Inc. | 2 | $28 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Seagen Inc. | 2 | $26 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Caris MPI, Inc. | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Lexicon Pharmaceuticals, Inc. | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Verastem, Inc. | 1 | $14 |
| EMD Serono, Inc. | 1 | $13 |
| Gilead | 1 | $12 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$33,414 in reported general payments places this provider in the 60th percentile of 838 hematology & oncology providers in Texas.
Other hematology & oncology in San Antonio
- Kyriakos PapadopoulosSan Antonio$18.5M
- Drew RascoSan Antonio$14.1M
- David SommerhalderSan Antonio$10.4M
- Emmalind AponteSan Antonio$4.4M
- Manuel SantiagoSan Antonio$3.9M
- Paul ShaughnessySan Antonio$3.7M
- Ildefonso Rodriguez RiveraSan Antonio$2.7M
- Sharon WilksSan Antonio$2.5M
- Elias JabbourHouston$264.1M
- Luhua WangHouston$79.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.